top of page


MAJI Moves to Cancel Over 15M Shares As It Pushes Toward Commercialization
Glioblastoma is one of medicine's most formidable enemies. It's a brain cancer so aggressive that for decades, even the most advanced...

Checkers
Sep 43 min read
Â
Â


MAJI: Ushering In A New Era With Transformative Biotech Acquisition
A significant transformation is underway for the OTC PINK listed MAJI. The company is executing a high-profile acquisition of Exousia...

Checkers
Dec 16, 20243 min read
Â
Â
bottom of page



